The Informed Consent and Medical Transparency Act establishes new requirements for drug manufacturers, hospitals, and healthcare providers in Oklahoma to enhance patient awareness and informed consent regarding medical treatments. Under this act, drug manufacturers are mandated to create and distribute a plain-language summary of known or suspected side effects of their products, which must be provided to healthcare facilities and published on a public website. Hospitals and healthcare providers are required to ensure that patients or their legal guardians receive this summary before any drug, vaccine, or biologic is administered or prescribed. Additionally, any adverse events or side effects must be documented and reported to the State Board of Pharmacy within ten business days.

The act also introduces civil liability for manufacturers, hospitals, or providers that fail to comply with these requirements, allowing patients to seek damages for injuries resulting from a lack of informed consent. The legislation emphasizes transparency and encourages the liberal interpretation of its provisions to promote informed decision-making without conflicting with federal regulations. The act is set to take effect on November 1, 2026.